EMCDDA Home
  • EN
Search

Figure INF-6. HCV antibody prevalence among injecting drug users - studies with national and subnational coverage

Part (ii) Young injecting drug users (under age 25), 2009 to 2010

 
 

Notes:

Black squares are samples with national coverage; blue triangles are samples with subnational (including local or regional) coverage. Differences between countries have to be interpreted with caution owing to different types of settings and/or study methods; national sampling strategies vary. Countries are presented by order of increasing prevalence, based on the average of national data or, if not available, of subnational data.

Source:

Reitox network.

Country Czech Republic Malta Slovenia Hungary Slovakia Austria United Kingdom Poland Belgium Sweden Finland Greece Cyprus Portugal Bulgaria Romania
National 10.7 13.0 13.2 17.5   19.2           52.4 56.3 57.1    
National           36.1           38.7        
Subnational       1.2 22.2 66.7 26.0 54.5 71.4 41.2 44.6 40.0     65.7 82.7
Subnational       40.7   55.0 25.4 17.6 8.3     52.4        
Subnational       47.7   36.6 25.3         41.3        
Subnational       28.6     13         20.0        
Subnational       16.4     76.9         70.0        

inffig6b

 

About the EMCDDA

The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) is the reference point on drugs and drug addiction information in Europe. Inaugurated in Lisbon in 1995, it is one of the EU's decentralised agencies. Read more >>

Contact us

EMCDDA
Praça Europa 1, Cais do Sodré
1249-289 Lisbon
Portugal
Tel. (351) 211 21 02 00
Fax (351) 218 13 17 11

More contact options >>

Page last updated: Friday, 20 July 2012